Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

PURPOSE: To investigate the efficacy and safety of transarterial chemoembolization (TACE) combined with lenvatinib plus PD-1 inhibitor (TACE-L-P) versus TACE combined with lenvatinib (TACE-L) for patients with advanced hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Data of advanced HCC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Mingyue, Huang, Wensou, Huang, Jingjun, Shi, Wenbo, Guo, Yongjian, Liang, Licong, Zhou, Jingwen, Lin, Liteng, Cao, Bihui, Chen, Ye, Zhou, Juan, Zhu, Kangshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921060/
https://www.ncbi.nlm.nih.gov/pubmed/35300325
http://dx.doi.org/10.3389/fimmu.2022.848387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921060/
https://www.ncbi.nlm.nih.gov/pubmed/35300325
http://dx.doi.org/10.3389/fimmu.2022.848387

Ejemplares similares